Tumors Induced in Newborn Mice by Chemical Carcinogens
Author Information
Author(s): F. J. C. Roe, K. E. K. Rowson, M. H. Salaman
Primary Institution: London Hospital Medical College
Hypothesis
Can chemical carcinogens induce tumors in newborn mice?
Conclusion
The study confirms that injecting newborn mice with DMBA leads to a higher incidence of various tumors compared to control groups.
Supporting Evidence
- Injection of DMBA led to a higher incidence of malignant lymphoma and lung tumors.
- DMBA-treated mice had an average of over 12 tumors per mouse after one year.
- Control mice showed no deaths from tumors.
- Malignant lymphoma appeared significantly earlier in the '101' strain compared to CBA mice.
- Telangiectases were observed in the forestomach of DMBA-treated mice.
Takeaway
When baby mice are given a chemical that can cause cancer, they can get sick and develop tumors much more easily than mice that didn't get the chemical.
Methodology
Newborn mice were injected with DMBA and monitored for tumor development over one year.
Limitations
Some mice died before post-mortem examination, and not all tumors were examined microscopically.
Participant Demographics
Two strains of inbred mice, CBA and '101', were used.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website